(Q83324112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Andrew J Armstrong

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Mario Eisenberger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

246-247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16691232%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ncpuro0462

21 January 2020

exact match

0 references

cites work

Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0462

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0462

7 January 2021

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0462

7 January 2021

Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0462

7 January 2021

Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0462

7 January 2021